Core Historical Financial Ratios
| CORZ Stock | USD 9.86 0.94 8.70% |
Core Scientific, is presently reporting on over 79 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, Days Sales Outstanding of 2.39 or Free Cash Flow Yield of 0.0354 will help investors to properly organize and evaluate Core Scientific, Common financial condition quickly.
Core |
About Core Financial Ratios Analysis
Core Scientific, CommonFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Core Scientific, investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Core financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Core Scientific, history.
Core Scientific, Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Core Scientific, Common stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Core Scientific, sales, a figure that is much harder to manipulate than other Core Scientific, Common multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Stock Based Compensation To Revenue
A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Free Cash Flow Per Share
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Most ratios from Core Scientific,'s fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Core Scientific, Common current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Scientific, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Core Scientific,'s Days Payables Outstanding is fairly stable compared to the past year. EV To Operating Cash Flow is likely to rise to 30.79 in 2025, despite the fact that PTB Ratio is likely to grow to (2.39).
| 2024 | 2025 (projected) | Payables Turnover | 2.82 | 2.68 | Days Of Inventory On Hand | 376.12 | 334.33 |
Core Scientific, fundamentals Correlations
Click cells to compare fundamentals
Core Scientific, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Core Scientific, fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 2.46 | 1.31 | 1.83 | 2.6 | 2.99 | 3.06 | |
| Ptb Ratio | 1.66 | 0.51 | (2.86) | (2.19) | (2.52) | (2.39) | |
| Days Sales Outstanding | 6.7 | 1.13 | 0.15 | 5.2 | 4.68 | 2.39 | |
| Book Value Per Share | 2.07 | 6.69 | (1.2) | (1.57) | (1.81) | (1.72) | |
| Free Cash Flow Yield | (0.17) | (0.16) | (0.15) | 0.0375 | 0.0337 | 0.0354 | |
| Operating Cash Flow Per Share | (0.55) | (0.27) | 0.6 | 0.17 | 0.15 | 0.16 | |
| Stock Based Compensation To Revenue | 0.0503 | 0.0715 | 0.29 | 0.12 | 0.11 | 0.088 | |
| Pb Ratio | 1.66 | 0.51 | (2.86) | (2.19) | (2.52) | (2.39) | |
| Ev To Sales | 2.98 | 2.57 | 1.81 | 4.22 | 4.86 | 3.81 | |
| Roic | 0.0285 | 0.0562 | (0.37) | 0.0244 | 0.022 | 0.0231 | |
| Net Income Per Share | (2.41E-4) | 0.23 | (6.3) | (0.65) | (0.75) | (0.78) | |
| Payables Turnover | 16.66 | 26.31 | 11.78 | 2.45 | 2.82 | 2.68 | |
| Sales General And Administrative To Revenue | 0.24 | 0.11 | 0.33 | 0.19 | 0.17 | 0.18 | |
| Research And Ddevelopement To Revenue | 0.0874 | 0.0141 | 0.0421 | 0.0143 | 0.0164 | 0.0156 | |
| Capex To Revenue | 0.026 | 0.11 | 0.6 | 0.0322 | 0.037 | 0.0351 | |
| Cash Per Share | 0.2 | 0.64 | 0.15 | 0.13 | 0.12 | 0.19 | |
| Pocfratio | (6.24) | (12.57) | 5.71 | 20.07 | 18.06 | 18.96 | |
| Interest Coverage | (0.002344) | 3.76 | (2.53) | 0.1 | 0.0935 | 0.0982 | |
| Capex To Operating Cash Flow | (0.066) | (1.04) | 1.87 | 0.25 | 0.22 | 0.23 | |
| Pfcf Ratio | (5.86) | (6.15) | (6.55) | 26.69 | 24.02 | 25.23 | |
| Days Payables Outstanding | 21.91 | 13.87 | 30.98 | 149.06 | 134.15 | 140.86 | |
| Income Quality | 1.95 | (1.2) | (0.0956) | (0.26) | (0.3) | (0.29) | |
| Roe | (1.17E-4) | 0.0341 | 5.24 | 0.41 | 0.37 | 0.35 | |
| Ev To Operating Cash Flow | (7.57) | (24.68) | 5.64 | 32.59 | 29.33 | 30.79 | |
| Pe Ratio | (14.3K) | 15.07 | (0.55) | (5.3) | (4.77) | (5.01) | |
| Return On Tangible Assets | (6.5E-5) | 0.0344 | (2.66) | (0.35) | (0.4) | (0.42) | |
| Ev To Free Cash Flow | (7.1) | (12.07) | (6.47) | 43.34 | 39.01 | 40.96 | |
| Earnings Yield | (7.0E-5) | 0.0664 | (1.83) | (0.19) | (0.22) | (0.23) | |
| Intangibles To Total Assets | 0.29 | 0.44 | 0.00211 | 0.003155 | 0.003628 | 0.003447 | |
| Net Debt To E B I T D A | (3.0K) | 4.1 | 0.007883 | (12.91) | (11.62) | (12.2) | |
| Current Ratio | 1.02 | 2.36 | 0.46 | 0.2 | 0.23 | 0.22 | |
| Tangible Book Value Per Share | 0.56 | 1.55 | (1.21) | (1.58) | (1.81) | (1.72) | |
| Receivables Turnover | 54.49 | 323.71 | 2.5K | 70.18 | 63.16 | 60.0 | |
| Graham Number | 0.11 | 5.86 | 13.05 | 4.79 | 4.31 | 3.95 | |
| Shareholders Equity Per Share | 2.07 | 6.69 | (1.2) | (1.57) | (1.81) | (1.72) | |
| Debt To Equity | 0.45 | 0.59 | (0.0922) | (1.45) | (1.67) | (1.58) | |
| Graham Net Net | (2.27) | (4.44) | (3.42) | (3.3) | (3.79) | (3.98) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Core Stock Analysis
When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.